Sign in

You're signed outSign in or to get full access.

Darby Anderson

Executive Vice President, Chief Government Relations Officer at Addus HomeCare
Executive

About Darby Anderson

Darby Anderson, age 59, is Executive Vice President and Chief Government Relations Officer at Addus HomeCare, serving in this role since April 2022 after prior leadership posts in strategy and corporate development; he joined Addus in 1996 and holds a B.A. from Michigan State University . His annual incentives and performance-based equity are tied solely to Adjusted EBITDA, with 2024 outcomes at 112% of target leading to maximum cash and equity payouts; the company’s pay-versus-performance framework highlights Adjusted EBITDA and shareholder return as the primary alignment metrics . The company’s insider trading policy prohibits hedging, pledging, margin accounts, short sales, and unauthorised standing orders, supporting ownership alignment .

Past Roles

OrganizationRoleYearsStrategic Impact
Addus HomeCare CorporationEVP & Chief Government Relations OfficerApr 2022 – presentLeads government relations impacting reimbursement and regulatory positioning
Addus HomeCare CorporationEVP & Chief Strategy OfficerNov 2019 – Mar 2022Directed corporate strategy and long-term planning
Addus HomeCare CorporationEVP & Chief Development Officer2014 – Nov 2019Led corporate development and growth initiatives
Addus HealthCareSenior Vice President2013 – 2014Oversaw operational leadership in home and community services
Addus HealthCareRegional Manager; Regional VP (Midwest/East); VP Home & Community Services1996 – 2013Progressive field and operational leadership roles

External Roles

No external public company board roles disclosed in the 2024/2025 DEF 14A filings for Mr. Anderson .

Fixed Compensation

Multi-year cash compensation history (as reported in Summary Compensation Tables):

Metric202220232024
Base Salary ($)373,885 387,308 399,692
Non-Equity Incentive Plan Compensation ($)282,000 409,500 452,250
All Other Compensation ($)30,363 29,962 31,055

Bonus targets and actuals (percentage of base salary):

Metric202320242025 (Target)
Target Bonus (% of Base Salary)75% 75% 75%
Actual Earned (% of Base Salary)105% 112.5%

2024 “All Other Compensation” components for Mr. Anderson: life insurance $13,015; company health/dental/vision contributions $16,840; cell phone allowance reimbursement $1,200; total $31,055 .

Performance Compensation

Performance-based cash and equity structure is entirely tied to Adjusted EBITDA, with calibrated thresholds and caps:

ComponentMetricWeightingTargetActualPayoutVesting
Annual Cash Incentive (2024)Adjusted EBITDA100%75% of salary target; 50% payout at 90% of EBITDA target; max 150% at 110% Company achieved 112% of target 150% of target award; Mr. Anderson earned 112.5% of base salary Cash (paid Mar 5, 2025)
Performance-Based Equity (granted Feb 21, 2025 for 2024 performance)Adjusted EBITDA100%Fixed dollar target $375,000 112% achieved; max 150% payout Converted to 5,150 restricted shares Vests over three years on Feb 21, 2026/2027/2028

Additional equity grants and awards:

  • 2024 annual grant: 5,657 restricted shares granted on Feb 23, 2024; grant-date fair value $504,039 .
  • Company disclosed it did not make any option grants in 2024 (options available under A&R 2017 Plan, but none granted that year) .

Option exercises and stock vesting history:

Metric20232024
Options Exercised (# / $ value realized)12,698 / $806,181 — / —
Stock Awards Vested (# / $ value realized)3,736 / $396,858 3,693 / $329,046

Equity Ownership & Alignment

Beneficial ownership and unvested equity:

MetricValue
Beneficial Ownership (shares), as of Apr 23, 202587,045; less than 1% of outstanding
Unvested Restricted Stock (shares) as of Dec 31, 20249,709 shares; market value $1,217,023 at $125.35/share
Insider Trading PolicyProhibits hedging, pledging, margin accounts, short sales, and unauthorised standing orders

Outstanding options as of Dec 31, 2024:

Exercisable Options (#)Exercise Price ($)Expiration
20,000 22.70 03/01/2026
6,740 34.05 03/03/2027
6,161 37.25 03/02/2028
10,000 37.25 03/02/2028

Note: Company common stock closed at $125.35 on Dec 31, 2024 (used by the proxy to value unvested restricted shares), indicating these option tranches were in-the-money at year-end .

Employment Terms

Key employment agreement terms and severance/CoC economics:

TermDetail
AgreementAmended & Restated employment agreement effective Nov 5, 2018; initial term four years from Aug 27, 2007 start; auto-renews for successive one-year terms unless 30 days’ notice
Salary/Bonus in AgreementBase salary $325,000 (subject to annual review); annual bonus up to 75% of base salary, performance vs Company/individual objectives
BenefitsParticipation in standard plans; life insurance policy up to 5x salary, Company not required to pay >3% of salary for premiums
Restrictive CovenantsNon-compete within 50 miles of any Company location; non-solicit (customers, employees, referral sources, suppliers, vendors); nondisparagement; confidentiality; covenants apply for 1 year post-termination, or 2 years upon Change in Control for non-CEO NEOs
Post-termination Option ExerciseGenerally 3 months post-termination; 6 months upon Retirement; 12 months upon death or Disability; forfeiture upon termination for Cause
Clawback (Recoupment)Compensation recovery policy adopted Nov 24, 2023; filed as Exhibit 97.1 to 2024 Form 10-K
Tax Gross-upsNo tax gross-ups for change-in-control payments
Pension/Deferred CompNo participation in defined benefit pension or nonqualified deferred compensation plans

Potential payments upon termination (assuming termination on Dec 31, 2024):

ScenarioSeverance ($)Extension of Benefits ($)Accelerated Equity Vesting ($)Total ($)
Without Reasonable Cause or for Good Reason1,229,250 16,840 1,246,090
Without Reasonable Cause or Good Reason in Connection with Change in Control2,157,000 33,680 1,217,023 3,407,703
Disability1,217,023 1,217,023
Death1,217,023 1,217,023

Change-in-control severance enhancements for non-CEO NEOs (structure/multiples):

  • 24 months of annual cash compensation (highest base salary + greater of prior year’s bonus or current-year target bonus), payable in equal installments for 12 months post-termination; pro rata bonus; after-tax cash equal to Company’s share of 24 months of COBRA premiums, payable in equal installments for one year .
  • Equity awards: immediate vesting upon Change in Control if actively employed, or upon death/Disability .

Investment Implications

  • Pay-for-performance alignment is tight: cash and equity awards are 100% tied to Adjusted EBITDA with a steep payout curve (50% at 90% of target; 150% at 110%), and 2024 outperformance at 112% drove maximum payouts; for 2025, this single metric remains in place, signaling strong linkage to operational profitability rather than TSR or revenue growth .
  • Near-term selling pressure is modest: Anderson had no option exercises in 2024 and limited stock vesting (3,693 shares), while performance RSUs granted in 2025 vest across 2026–2028, staging future supply; the company prohibits hedging/pledging, mitigating alignment risk .
  • Retention risk appears contained: auto-renewing employment agreement, meaningful severance protections (24-month cash multiple upon CoC), and robust restrictive covenants (non-compete/non-solicit) support continuity; equity accelerates on CoC, which is shareholder-sensitive but can incentivize management stability through potential transactions .
  • Ownership alignment: 87,045 shares beneficially owned (<1%); 9,709 unvested restricted shares valued at $1.217M at year-end; outstanding options are all deeply in-the-money vs the $125.35 year-end price, enhancing long-term alignment and potential future exercises tied to liquidity windows .
  • Governance safeguards: Dodd-Frank clawback implemented (Nov 2023), and explicit bans on hedging/pledging reduce headline risk; no tax gross-ups on CoC payments, which is shareholder-friendly .